| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |